TOP
|
特許
|
意匠
|
商標
商標ウォッチ
Twitter
他の商標を見る
公開日
2025-07-24
公報種別
公開国際商標公報
国際登録番号
1855735
国際登録日
2025-03-10
区分
第5類(薬剤)
,
第42類(科学・技術)
商品役務
Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders
,
autoimmune deficiency; pharmaceutical preparation and substances for the treatment of genetic disorders; pharmaceutical preparations and substances for the treatment of metabolic diseases; pharmaceutical preparations and substances for the treatment of neurodegenerative diseases; pharmaceutical preparations and substances for the treatment of kidney diseases; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodies
,
buffers
,
and reagents for use in disease testing; diagnostic preparations for medical purposes for detecting the presence of tumors
,
genetic disorder and autoimmune disorders and conditions; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders
,
autoimmune deficiency; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodies
,
buffers
,
and reagents for use in disease testing; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of oncological diseases and disorders
,
autoimmune diseases and disorders
,
autoimmune deficiency
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
cardiovascular diseases; all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases.
,
Research and development services in the field of biologics
,
namely
全 95 件を表示
,
antibodies and peptides for the treatment of cancer and immunotherapies; research and development in the pharmaceutical and biotechnology fields for the treatment of cancer and immunotherapies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of cancer and immunotherapies; consulting services in the fields of biotechnology
,
pharmaceutical research and development
,
and pharmacogenetics in the field of cancer and immunotherapies; conducting research for others in the field of biotechnology
,
pharmaceutical research and development
,
laboratory testing
,
diagnostics
,
and pharmacogenetics in the field of cancer and immunotherapies; research and development services in the field of biologics
,
namely
,
antibodies and peptides for the field of autoimmune diseases
,
autoimmune disorders
,
metabolic diseases
,
neurodegenerative diseases
,
and kidney diseases; research and development in the pharmaceutical and biotechnology fields for the treatment of autoimmune diseases
,
autoimmune disorders
,
metabolic diseases
,
neurodegenerative diseases
,
and kidney diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of autoimmune diseases
,
autoimmune disorders
,
metabolic diseases
,
neurodegenerative diseases
,
and kidney diseases; consulting services in the fields of biotechnology
,
pharmaceutical research and development
,
and pharmacogenetics in the field of autoimmune diseases
,
autoimmune disorders
,
metabolic diseases
,
neurodegenerative diseases
,
and kidney diseases; conducting research for others in the field of biotechnology
,
pharmaceutical research and development
,
laboratory testing
,
diagnostics
,
and pharmacogenetics in the field of autoimmune diseases
,
autoimmune disorders
,
metabolic diseases
,
neurodegenerative diseases
,
and kidney diseases; pharmaceutical research and development; research and development in the field of biologics
,
namely
,
antibodies and peptides for the field of cancer
,
immunotherapies
,
autoimmune diseases
,
autoimmune disorders
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
and cardiovascular diseases; research and development in the field of pharmaceuticals
,
biopharmaceuticals
,
and biotechnologies for the treatment of cancer
,
immunotherapies
,
autoimmune diseases
,
autoimmune disorders
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
and cardiovascular diseases; research and development in the field of biotechnology
,
pharmaceutical research and development
,
laboratory testing
,
diagnostics
,
and pharmacogenetics in the field of cancer
,
immunotherapies
,
autoimmune diseases
,
autoimmune disorders
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases eye diseases
,
and cardiovascular diseases; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; consulting services in the field of biotechnology; consulting services in the field of pharmacogenetics; research and development in the field of oncological diseases and disorders
,
autoimmune diseases and disorders
,
autoimmune deficiency
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
cardiovascular diseases; all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases.
基礎出願番号
98745375,88622674,99074324
基礎出願日
2024-09-11,2019-09-19,2025-03-08
基礎出願国
US,US,US
出願人
DynamiCure Biotechnology, LLC
OCRテキスト
DYNAMICURE
OCRテキスト2
DYNAMICURE
OCRについて
この商標をJ-PlatPatで参照する
関連商標
Bayer Consumer Care AG
BEPANTHEN
3か月前
Triticum Exploitatie B.V.
L-MESITRAN
8か月前
Novartis AG
OJUVIP
8か月前
JADRAN - GALENSKI LABORATORIJ d.d.
MERALYS
6か月前
ROXALL Medizin GmbH
SULGEN
2か月前
ROXALL Medizin GmbH
ROXALL
2か月前
個人
GI-MASK
11か月前
ROXALL Medizin GmbH
2か月前
Orion Corporation
ORIONPHARMA
4か月前
個人
SPEEDEX
6か月前
COSWELL S.p.A.
BLANX
11か月前
BOLERO & Co Ltd.
BOLERO
7か月前
個人
LuxatempMaxProtect
5か月前
Precision Hydration Limited
PRECISIONFUEL&HYDRATION
28日前
個人
GET ONE
7か月前
Natural Innovations Group Pty Ltd
phytocannbp
9か月前
Evinature Ltd
2か月前
個人
Gönrgy
10か月前
Perfect Care Distribution
Halova
10か月前
Boehringer Ingelheim Vetmedica GmbH
SOLECTUS
6か月前
BIG SHOT DEVELOPMENTS LTD.
BIGSHOT
11か月前
Bausch Health Ireland Limited
CABTREO
11か月前
Merz Pharma GmbH & Co. KGaA
XEOMIN
9か月前
DAEWOONG CO., LTD.
DAEWOONGPET
11か月前
RAUMEDIC AG
ThermMotion
11か月前
PECTEN GROUP S.R.L.
DEAVOCADO
5か月前
REGENXBIO Inc.
NAVSUNLI
5か月前
INTACT
INTACT REGENERATIVE
7か月前
Hermes Arzneimittel GmbH
2か月前
TerraPower, LLC
tpi TERRAPOWER ISOTOPES
6か月前
Opti Licences Pty Ltd
OptiSlim
9か月前
PAUL HARTMANN AG
PREVENTIA
2か月前
TerraPower, LLC
5か月前
INTERSALES COMPANY, naamloze vennootschap
FORNATURAL ENERGY MALT DRINK AND VITALITY
10か月前
Aspivix SA
ASPIVIX
2か月前
Vetsense Pty Ltd
VETSENSE
10か月前
続きを見る
他の商標を見る